Table 1.
Baseline demographics and comorbidities of patients in the different treatment groups.
| Variable | EVT - Selective Stenting | EVT- Routine Stenting | CFE |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Total studies | 8 | 7 | 14 |
|
| |||
| Number of patients | 646 | 289 | 1756 |
|
| |||
| Number of limbs | 678 | 306 | 1930 |
|
| |||
| Mean Age [years] | 68.4 | 68.8 | 69.9 |
|
| |||
| Males | 399 (61.7) | 202 (69.8) | 1299 (73.9) |
|
| |||
| Females | 247 (38.3) | 87 (30.2) | 457 (26.1) |
|
| |||
| Diabetes Mellitus | 253 (39.1) | 102 (35.2) | 736 (41.9) |
|
| |||
| Coronary Artery Disease | 357 (55.2) | 105 (36.3) | 1069 (60.8) |
|
| |||
| Hypertension | 451/531 # (84.9) | 241 (83.3) | 1504 (85.6) |
|
| |||
| Hyperlipidemia | 317/531 # (59.6) | 183 (63.3) | 1106/1666 ∗ (66.3) |
|
| |||
| Smokers | 241/531 # (45.3) | 171 (59.1) | 1074 (61.1) |
|
| |||
| End Stage Renal Disease | 84/305 @ (27.5) | 19/109 (17.4)¶ | 164/1379 ∧ (11.8) |
|
| |||
| Claudication | 419 (64.8) | 191 (66.1) | 943 (53.7) |
|
| |||
| CLI | 227 (35.1) | 97 (33.5) | 1021 (58.1) |
[@ 3 out of 8 studies | # 7 out of 8 studies | ∗ 12 out of 13 studies | ∧ 9 out of 13 studies].